• ARTICLE 1 General Provisions
    • 26-1-1. Short title.
    • 26-1-2. Definitions.
    • 26-1-3. Prohibited acts.
    • 26-1-3.1. Repealed.
    • 26-1-3.2. Prescription drug donation.
    • 26-1-4. Power to enjoin violations.
    • 26-1-5. Penalty; exemptions.
    • 26-1-6. Detection of drugs, devices or cosmetic believed adulterated, misbranded or counterfeit; condemnation; destruction or correction of defect; forfeiture and sale.
    • 26-1-7. Attorney general or district attorney to institute prosecutions.
    • 26-1-8. Minor violations of act; warnings authorized.
    • 26-1-9. Addition of poisonous or deleterious substances; color additives.
    • 26-1-10. Drug or device adulteration.
    • 26-1-11. Drug or device; misbranding.
    • 26-1-12. False advertising.
    • 26-1-13. Packaging and labeling requirements; proprietary preparations.
    • 26-1-14. New drugs and devices; prerequisites to sale, delivery or giving away; exceptions.
    • 26-1-15. Dangerous drugs; veterinary use; limitations.
    • 26-1-16. Dangerous drugs; conditions for sale; prescription refilling; limitations.
    • 26-1-16.1. Opioids; requiring practitioners to obtain and review reports from the prescription monitoring program.
    • 26-1-17. Testing laboratory.
    • 26-1-18. Promulgating regulations; procedure.
    • 26-1-18.1. Prescription drug prior authorization protocols.
    • 26-1-19. Power to make inspections and secure samples.
    • 26-1-20. Personnel.
    • 26-1-21. Power of board to publish reports and disseminate information.
    • 26-1-22. Unlawful means of obtaining dangerous drugs enumerated.
    • 26-1-23. False statements; false pretenses; forgery of labels or prescriptions prohibited.
    • 26-1-24. Cosmetics; misbranding.
    • 26-1-25. Cosmetics; adulteration.
    • 26-1-26. Penalties.
  • ARTICLE 2 Drug Abuse (Repealed, Recompiled.)
    • 26-2-1 to 26-2-4. Repealed.
    • 26-2-4.1. Recompiled.
    • 26-2-5 to 26-2-14. Repealed.
  • ARTICLE 2A Controlled Substances Therapeutic Research
    • 26-2A-1. Short title.
    • 26-2A-2. Purpose.
    • 26-2A-3. Definitions.
    • 26-2A-4. Lynn Pierson therapeutic research program established; participation.
    • 26-2A-5. Patient qualification review board; composition; powers and duties.
    • 26-2A-6. Lynn Pierson therapeutic research program; distribution.
    • 26-2A-7. Report.
  • ARTICLE 2B Lynn and Erin Compassionate Use Act
    • 26-2B-1. Short title.
    • 26-2B-2. Purpose of act.
    • 26-2B-3. Definitions.
    • 26-2B-4. Exemption from criminal and civil penalties for the medical use of cannabis.
    • 26-2B-5. Prohibitions, restrictions and limitations on the medical use of cannabis; criminal penalties.
    • 26-2B-6. Advisory board created; duties.
    • 26-2B-6.1. Assessment reporting.
    • 26-2B-7. Registry identification cards; department rules; duties; reciprocity.
    • 26-2B-7.1. Registry identification card; registration; renewal; written certification.
    • 26-2B-8. THC content; no limitation.
    • 26-2B-9. Employment protections.
    • 26-2B-10. Persons under state supervision; protections.
  • ARTICLE 2C Cannabis Regulation
    • 26-2C-1. Short title.
    • 26-2C-2. Definitions.
    • 26-2C-3. Division; powers and duties; rulemaking; advisory committee created; membership; duties.
    • 26-2C-3.1. Criminal history background checks; processes and procedures.
    • 26-2C-4. Department of health; duties; public health and safety advisory committee.
    • 26-2C-5. Department of health; duties; transfer of licensing duties.
    • 26-2C-6. Licensing cannabis activities; limitations; medical cannabis legacy licensing; cannabis shortage for medical program; conversion of nonprofit medical cannabis corporations.
    • 26-2C-7. Cannabis activity licensing; application; issuance and denial of a license; suspension and revocation.
    • 26-2C-8. Licensees; disciplinary actions; sanctions; civil penalty.
    • 26-2C-9. Application and licensing fees.
    • 26-2C-10. Cannabis training and education programs; registration with division.
    • 26-2C-11. Cannabis server permits; cannabis servers; permit required; applications; education program approval required; issuance or denial of a permit or approval; penalties.
    • 26-2C-12. Local control.
    • 26-2C-13. Licensee protections.
    • 26-2C-14. Protection of underage persons; providing cannabis products to minors; penalties.
    • 26-2C-15. Transport via courier.
    • 26-2C-16. Packaging and labeling.
    • 26-2C-17. Cannabis products; packaging and labeling; division rulemaking.
    • 26-2C-17.1. When cannabis deemed misbranded.
    • 26-2C-18. Testing cannabis products; health and safety of employees and consumers.
    • 26-2C-18.1. When cannabis product deemed adulterated.
    • 26-2C-19. Researching cannabis; recordkeeping.
    • 26-2C-20. Advertising and marketing restrictions.
    • 26-2C-21. Contracts.
    • 26-2C-22. Provision of professional services.
    • 26-2C-23. Medical cannabis provisions unaffected.
    • 26-2C-24. Protections for the use of cannabis.
    • 26-2C-25. Personal use of cannabis.
    • 26-2C-26. Limits on personal use; penalties.
    • 26-2C-27. Personal production of cannabis; penalties.
    • 26-2C-28. Trafficking cannabis products; penalties.
    • 26-2C-29. Cannabis within restricted area; penalty.
    • 26-2C-30. Unlawful possession of cannabis; penalties.
    • 26-2C-31. Unlicensed manufacturing of cannabis extract; penalty.
    • 26-2C-32. Exemption from criminal and civil penalties; researchers.
    • 26-2C-33. Reporting requirements for cannabis-related violations.
    • 26-2C-34. Employer protections; exemptions.
    • 26-2C-35. Appeal of rules.
    • 26-2C-36. Public records and open meetings.
    • 26-2C-37. Intrastate source.
    • 26-2C-38. Imports and exports.
    • 26-2C-39. Cannabis regulation fund.
    • 26-2C-40. Plant limit.
    • 26-2C-41. Indian nations, tribes and pueblos; intergovernmental agreements.
    • 26-2C-42. Cooperation of agencies.
  • ARTICLE 3 Drug Product Selection
    • 26-3-1. Short title.
    • 26-3-2. Purpose.
    • 26-3-3. Drug and biological product selection permitted; conditions; exception for prohibition; labeling.
  • ARTICLE 4 Wholesale Prescription Drug Importation
    • 26-4-1. Short title.
    • 26-4-2. Definitions.
    • 26-4-3. Advisory committee created; membership; duties.
    • 26-4-4. Wholesale prescription drug importation program created.
    • 26-4-5. Monitoring for anti-competitive behavior.
    • 26-4-6. Federal compliance.
    • 26-4-7. Implementation.
    • 26-4-8. Annual reporting.
    • 26-4-9. Wholesale prescription drug importation fund.
    • 26-4-10. Countries other than Canada allowed by federal law.
Sort by:

The search engine retrieves document sections containing at least one of your query terms.

You may refine your search by using Boolean syntax:

Find Operator (case sensitive) Example
This phrase "" "R. v. Douglas"
All of these words AND permit AND hunting
Any of these words OR, no operator city municipality
Words within the same paragraph /p levy /p probate
Words within the same sentence /s tax /s income
Words within n words /n letter /5 credit
Exclude plurals and derivatives EXACT() EXACT(translator)
ALL possible ENDINGS * constitu*

You need to be signed in to annotate documents.

Login or sign up.

NMSA Unannotated

Decision Information

Decision Content

Footnotes